NDI comments review: Industry urges FDA back to the drawing board

By Stephen Daniells & Claire Videau

- Last updated on GMT

Related tags Draft guidance Fda

One week on from the deadline for submission of comments on the FDA’s new dietary ingredients (NDI) draft guidance, we review the comments.

The US Food and Drug Administration (FDA) agreed to a 60 day extension to the initial 90 day comment period. After 150 days of study, cogitation and debate, industry has filed comments. And the overwhelming response is that the draft guidance is unworkable.

“Rip it up and start again”​, has been the over-riding response from the industry. In this video, Stephen Daniells looks at the main problem areas, and looks at the solutions being proposed.

FDA will now work its way through the comments, and there is no time limit on a response. We may hear something in six weeks, six months, or longer.

What the industry does not want is for the draft guidance to pass into regulatory limbo.

Video filmed and edited by Claire Videau.

Related topics Regulation NDI draft guidance

Related news

Show more

Follow us


View more